CellsBin® Closes Series A Financing Led by 108 BioCapital to Advance Its Rare-Cell Intelligence™ Platform
Investment will accelerate commercialization, strategic partnerships, product development and expansion of CellsBin's clinical and technical capabilities BRANFORD, Conn., Sept. 22, 2026 /PRNewswire/ -- CellsBin, a biotechnology company pioneering Rare-Cell Biology™, today announced the...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- New Study: Gen Z Debt Is Rising Faster Than Any Other Generation, Delaying Homeownership and Family Planning
- Dama Health Earns the NurseApproved Seal for Dama Assist, Its AI-Powered Clinical Platform for Hormone Health and Menopause Care
- Fairmont Schools SJC Launches "Little Warriors" Series to Help Families Navigate Early Childhood
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,200+ — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →